Novel Theranostics
- Submission status
- Open
- Submission deadline
In recent years, there has been a growing interest in the field of novel theranostics, which encompasses both Positron emission tomography (PET) imaging and radionuclide therapy. Theranostics aims to integrate diagnostic and therapeutic approaches to personalize patient care. PET imaging plays a crucial role in the diagnostics by enabling the visualization and characterization of specific biological targets and pathways relevant to disease pathology. Moreover, PET allows for the evaluation of novel radiotracers designed to target these biological markers, facilitating the development and optimization of targeted therapies.
This collection seeks submissions of original research from researchers and clinicians actively involved in applying PET imaging techniques with novel biological targets and radiotracers, as well as from scientists working on the development of new radiotracers for PET.
Editors
-
Anne M Landau, PhD
Aarhus University, Denmark
-
Mukesh K Pandey, PhD
Mayo Clinic Rochester, USA
Collections articles undergo Scientific Reports' standard peer review process and are subject to all of the journal’s standard policies. This includes the journal’s policy on competing interests. The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests. For more information, refer to our Collections guidelines.
This Collection has not been supported by sponsorship.
